Vertex Pharmaceuticals (VRTX) Non Operating Interest Expenses (2009 - 2026)
Vertex Pharmaceuticals (VRTX) reported Non Operating Interest Expenses of $3.3 million for Q4 2025, up 17.9% from $2.8 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
For FY2025, Vertex Pharmaceuticals posted Non Operating Interest Expenses of $13.3 million, down 56.5% from FY2024.
- Non Operating Interest Expenses has declined for three consecutive years, with a five-year compound annual growth rate of -25.6% (FY2020 to FY2025).
- By year, Non Operating Interest Expenses came in at $30.6 million in FY2024 (-30.6%), $44.1 million in FY2023 (-19.5%) and $54.8 million in FY2022.
- Five-year quarterly Non Operating Interest Expenses spans a low of $2.8 million in Q4 2024 and a high of $11.2 million in Q2 2023.
- Year over year, Non Operating Interest Expenses gained in 1 of the last seven quarters, with an average decline of 41.2%.
- Per Business Quant data, the three quarters before Q4 2025 came in at $3.3 million (Q3 2025), $3.7 million (Q2 2025) and $3 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | - |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 137.20 Bn | 109.19 Bn | 2.91 Bn | 36.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.00 Mn |
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 10.60 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Dec 31, 2020 | 16.29 Mn |
| Sep 30, 2020 | 13.86 Mn |
| Jun 30, 2020 | 13.87 Mn |
| Mar 31, 2020 | 14.14 Mn |
| Dec 31, 2019 | 14.25 Mn |
| Sep 30, 2019 | 14.55 Mn |
| Jun 30, 2019 | 14.84 Mn |
| Mar 31, 2019 | 14.87 Mn |
API Access
Vertex Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();